IMMUNODIAGNOSTIC SYSTEMS HOLDINGS (AIM:IDH) the expected excellent Interim Results
IDH operate in the in-vitro diagnostics (“IVD”) market and designs, manufactures and sells immunoassay kits. These are used to measure or detect particular substances within a sample, thus aiding the diagnosis or monitoring of a disease or providing information for research studies. In 2008 the company commented that the immunoassay sector of the IVD market was estimated to be worth US$14bn, a staggering number!
Revenue for the half year was up 34% to £22.6m, pre-tax…
Previous article Next article